Device Trial Radar · NCT03770065
Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women
Last checked: Nov 20, 2026Latest source record: Oct 6, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Nov 19, 2018
Primary completion
Dec 30, 2019
Study completion Apr 8, 2020
Sponsor
- Lead sponsor
- Viramal LimitedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 10, 2018
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- Female only, from 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study is designed to determine the effect on vaginal pH and the duration of action measured on the ability of the base formulation to reduce the vaginal pH
Conditions
- Vaginal Atrophy
Interventions
VML-0001Device
Medical device
Primary outcomes
What the sponsor says the trial is designed to measure.
- To determine the duration of action measured on the ability of VML-0001 (base formulation) to reduce vaginal pH.Time frame: 7-14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Medical Affiliated Research Center, Inc. (MARC)
Huntsville, Alabama
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.